+ CD45RA Ϫ central memory, whereas memory to Epstein-Barr virus (EBV) latent, EBV lytic, and cytomegalovirus (CMV) antigens are progressively larger in size and are more biased toward CCR7 Ϫ CD45RA Ϫ effector memory and CCR7 Ϫ CD45RA + terminally differentiated compartments. We found that these populations are also distinguished by progressively lower expression of the interleukin-7 receptor (IL-7Ra) and by lower IL-7 responsiveness; indeed, percentage IL-7Ra-positive values showed a tight inverse correlation with population size. However, these relationships among size, differentiation phenotype, and IL-7Ra status in blood did not hold in tonsillar tissue. In tonsil tissue, although EBV reactivities outnumbered their CMV and influenza counterparts, the distinct CCR7/CD45 isoform signatures of the different virus-specific populations were retained. Moreover, all detectable reactivities showed high levels of IL-7Ra expression. As a discriminator between different virus-specific populations, IL-7Ra therefore appears to be more susceptible to tissue location than the classical CCR7/CD45 markers.
In humans, circulating CD8 + memory T cells to a nonpersistent virus (influenza) lie within CCR7
+ CD45RA Ϫ central memory, whereas memory to Epstein-Barr virus (EBV) latent, EBV lytic, and cytomegalovirus (CMV) antigens are progressively larger in size and are more biased toward CCR7 Ϫ CD45RA Ϫ effector memory and CCR7 Ϫ CD45RA + terminally differentiated compartments. We found that these populations are also distinguished by progressively lower expression of the interleukin-7 receptor (IL-7Ra) and by lower IL-7 responsiveness; indeed, percentage IL-7Ra-positive values showed a tight inverse correlation with population size. However, these relationships among size, differentiation phenotype, and IL-7Ra status in blood did not hold in tonsillar tissue. In tonsil tissue, although EBV reactivities outnumbered their CMV and influenza counterparts, the distinct CCR7/CD45 isoform signatures of the different virus-specific populations were retained. Moreover, all detectable reactivities showed high levels of IL-7Ra expression. As a discriminator between different virus-specific populations, IL-7Ra therefore appears to be more susceptible to tissue location than the classical CCR7/CD45 markers.
Many viral infections elicit host CD8
+ T cell responses that act to bring the infection under control through a capacity to kill virus-infected cells. Thereafter, the immune host retains a population of virus-specific CD8 + T cells in the recirculating memory T cell pool [1, 2] . The factors that are important in maintaining such virus-specific memory are still not fully understood. From work in murine models, it is clear that cytokines of the common g-chain family, in particular interleukin (IL)-7 and IL-15, are required for the global maintenance and homeostatic proliferation of the memory T cell pool as a whole [3] [4] [5] [6] [7] [8] . In mice responding to lymphocytic choriomeningitis virus (LCMV) infection under conditions where the virus is cleared, reexpression of the IL-7 receptor (Ra) on CD8 + T cells has been shown to identify that subset of virus-specific cells within the primary response that are selected to memory [9] . However, for viruses that naturally persist in vivo, chronic antigenic stimulation may also contribute to the maintenance of memory. Indeed, in the LCMV model, under conditions leading to chronic virus infection, it was found that only a fraction of virusspecific CD8 + memory populations later express IL7Ra [10] .
The present work sought to address these questions in the context of human CD8 + T cell responses to different viruses-namely, the nonpersistent influenza virus and 2 persistent herpesviruses, Epstein-Barr virus (EBV) and cytomegalovirus (CMV). These agents are particularly interesting because they elicit memory CD8 + populations that differ both in size, as visualized by tetramer staining of peripheral blood mononuclear cells (PBMCs), and in phenotype, as defined by discriminating markers such as CCR7, CD62L, and the CD45 RA and RO isoforms [11] [12] [13] [14] [15] [16] . Indeed, within the EBV system itself there are differences in size and, to some extent, in phenotype between CD8 + T cell memory against the virus latent-cycle epitopes, as opposed to the virus lytic-cycle epitopes [17] [18] [19] . Furthermore, in a recent study that monitored individuals recovering from primary EBV infection, the emerging latent-and lytic-cycle memory populations showed different kinetics of IL7Ra acquisition, and both were significantly delayed, compared with the recovery of IL-7Ra on the CD8 + T cell population as a whole [20] .
After a preliminary report indicating that IL-7Ra expression may discriminate between memory populations to persistent versus nonpersistent viruses in humans [21] , we examined in more detail the common g-chain receptor status of influenza, EBV, and CMV-specific CD8 memory populations in blood from healthy adults, in relation to the size and differentiation status of those populations. Then, because our recent findings showed that the size of such populations can be quite different in tonsillar lymphoid tissue than in blood [22] , we extended the analysis to determine whether location might influence the cytokine-receptor and differentiation-marker status of these different virus-specific CD8 + populations. 
SUBJECTS, MATERIALS, AND METHODS

Donors
Tonsil specimens and matching heparinized blood samples were obtained from 11 patients with no history of EBV-related disease and who provided informed consent, as described elsewhere [22] . Mononuclear cells were isolated by purification over a Lymphoprep gradient (Nycomed) in accordance with the manufacturer's instructions. PBMCs were isolated in a similar manner from peripheral blood specimens obtained at the time of tonsillectomy or isolated from 25 additional healthy adults of known HLA type and with known EBV and CMV serologic results. These experiments were approved by the South Birmingham Health Authority Local Research Ethics Committee.
Phenotypic Analysis
Tetramer staining. The following HLA class I/epitope peptide tetramers were used: influenza epitopes [23] HLA-A2/GILGFV-FTL and HLA-B8/ELRSRYWAI; EBV latent epitopes [17, 24, 25] HLA-A2/CLGGLLTMV, HLA-B8/FLRGRAYGL and QAK-WRLQTL, and HLA-B35/YPLHEQHGM and HPVGEADY-FEY; EBV lytic epitopes [17, 24, 25] HLA-A2/GLCTLVAML and YVLDHLIVV, HLA-B8/RAKFKQLL, and HLA-B35/EPLP-QGQLTAY; and CMV epitopes [26] HLA-A2/NLVPMVATV and VLEETSVML, HLA-B8/ELRRKMMYM, ELKRKMIYM, and QIKVRVDMV, and HLA-B35/IPSINVHHY. Peptides were purchased from Alta Biosciences, and phycoerythrin (PE)-conjugated tetramers were produced as described elsewhere [17, 24, 25] . In stainings that included tetramers, cells were first incubated with PE-conjugated tetramer at 37ЊC for 15 min, and all further steps were conducted on ice.
Panel of anti-human cytokine receptors. Anti-human IL2Ra, IL-4Ra, and IL-21Ra were purchased from R&D Systems, and staining was detected using secondary fluorescein isothiocyanate (FITC)-conjugated swine anti-goat antibody (Caltag Laboratories).
IL receptor staining. Goat anti-human IL-7Ra antibody (R&D Systems) was detected using FITC-conjugated swine antigoat IgG antibody (Caltag Laboratories); mouse anti-human IL-15Ra (R&D Systems clone 151307) was detected using FITCconjugated goat anti-mouse IgG1 (Southern Biotechnology Associates) as described elsewhere [20] .
Activation status. In examining mononuclear cell subsets for CD38 expression, tetramer-PE-stained PBMCs were then exposed to the human IL-Ra-specific antibodies listed above, followed by an FITC-conjugated second-step reagent as described above, then washed and stained for 30 min on ice with Tricolour-labeled CD38 monoclonal antibody (MAb; Caltag Laboratories) and energy-coupled dye (ECD)-labeled CD8-specific MAb (Caltag Laboratories).
Differentiation phenotype. Prestained tetramer-PE-stained PBMCs were incubated with Tricolour-labeled CD8 MAbs (Caltag Laboratories) and FITC-labeled MAb to CCR7 (BD Biosciences) plus ECD-labeled anti-CD45RA (Caltag Laboratories) on ice for 30 min, then washed. All stainings were analyzed on an Epics flow cytometer (Beckman Coulter) with appropriate isotypes and color compensation.
Cellular Response to Cytokine Stimulation
PBMCs were exposed to PE-labeled tetramer for 15 min at 37ЊC in the presence of recombinant IL-7 (R&D Systems) at doses up to 100 ng/mL, then stained using rabbit anti-human phospho-signal transducer and activator of transcription factor (STAT)-5 MAb (Tyr694; Cell Signaling Technology), followed by FITC-conjugated goat anti-rabbit IgG (Southern Biotechnology Associates), in accordance with the manufacturer's instructions, and analyzed as described above. STAT5 phosphorylation analysis was conducted on between a minimum of 100 and a maximum of 1200 tetramer-positive cells, depending on the epitope.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software (version 4; GraphPad Prism). Data were compared using a Mann-Whitney U test, and significant differences were verified with 95% confidence intervals.
RESULTS
Size and cytokine-receptor status of virus-specific CD8
+ memory T cells in blood. Virus-specific CD8 + memory T cells in PBMC preparations from healthy adult donors were identified using PE-labeled HLA/peptide tetramers specific for 2 influenza epitopes, 5 EBV latent epitopes, 5 EBV lytic epitopes, and 6 CMV epitopes, all restricted through HLA A*0201, B*0801, or B*3501. At the same time, the cells were stained with Tricolourlabeled anti-CD8 and FITC-labeled antibodies against individual a-chains of the common g-chain cytokine receptor family. Figure 1 shows representative results from such an analysis on blood samples, focusing on the IL-7R and IL-15R a-chains. As shown in the left-hand columns, the size of circulating memory populations typically ranged from a low value for influenzaspecific, through intermediate values for EBV latent-specific and EBV lytic-specific, to the highest value for CMV-specific memory. The great majority of cells in all 4 virus-specific populations were IL-15Ra positive, as were CD8 + T cells as a whole. By contrast, the percentage of virus-specific memory cells expressing IL-7Ra decreased from 100% for influenza virus, through intermediate levels for EBV latent and lytic populations, to 25% for CMV; this was apparent even though the CD8 + T cell population as a whole was predominantly IL-7Ra positive. The overall results of such experiments are summarized in figure 2. These data come from a total of 25 healthy donors, most of whom had detectable memory to 3 if not 4 of the antigen specificities studied. This confirms that influenza-specific, EBV latent-specific, EBV lytic-specific, and CMV-specific memory populations are, in that order, progressively larger in size but progressively lower in their percentage of IL-7Ra-positive cells ( figure 2A-C) . Indeed, plotting individual values of IL-7Ra positivity versus response size showed remarkably strong correlations for all 4 sets of memory populations studied ( figure 2D ). By contrast, these same populations showed no difference in IL-15Ra status, with the majority of the cells always being IL-15Ra positive. Table 1 
+ T cells as a whole. The only possible exceptions were a tendency for influenza-specific cells to have higher IL-2Ra expression and for CMV-specific memory cells to be particularly low for IL-21Ra.
Size and cytokine-receptor status of virus-specific CD8 + memory T cells in tonsils. We then performed the same set of assays on tonsillar mononuclear cell preparations. Typical results from 1 such donor are shown in figure 3 . Here, as with almost all tonsil preparations, influenza-specific memory cells were undetectable. By contrast, EBV latent epitope CD8 + T cells were easily detected and were, in fact, more abundant than either EBV lytic epitope reactivities or CMV reactivities. Again, in contrast with the blood, all 3 virus-specific populations were strongly IL-7Ra positive, just as were total tonsillar CD8 + T cells as a whole. Staining for IL-15Ra likewise showed that the large majority of virus-specific and total CD8 T cell populations were receptor positive (data not shown). figure 2A . B, Scatter plots of interleukin (IL)-7-receptor-a (Ra) expression on CD8 + memory populations specific for EBV latent (black triangles), EBV lytic (black diamonds), and CMV epitopes (white triangles) in tonsils expressed as described in figure 2B . Horizontal lines show the median value for each virus. Statistical analysis was performed with GraphPad Prism software, and the P values of significance from the Mann-Whitney U test are indicated.
The overall results from an analysis of 12 tonsils (all from EBV-and CMV-positive donors, 8 of whom had an HLA type suitable for tetramer staining) are shown in figure 4 . These clearly showed that the hierarchy of size distribution, with EBV latent memory as most abundant and CMV as the least abundant, is the opposite of that in the blood. All 3 virus-specific populations had high percentages of IL-7Ra-positive cells, although, interestingly, the CMV memory population was significantly higher than the 2 EBV-specific populations. No differences were seen with respect to IL-15Ra status, which was consistently positive in the large majority of cells (data not shown).
IL-7Ra status and cytokine responsiveness. Given the differences in IL-7Ra profiles apparent from antibody staining experiments, we sought to determine whether such differences truly reflected the ability of the cells to respond to the cytokine itself. For this purpose, we used a fluorescence-based assay of cytokine-induced STAT5 phosphorylation to measure the response of individual cells to a brief exposure to IL-7 in vitro (100 and 1 ng/mL). Figure 5A shows typical results from one such assay conducted on matched blood and tonsil cell preparations from a single donor. As illustrated, levels of response (expressed as the percentage of cells stained with a phospho-STAT5-specific MAb) were larger at the higher IL-7 dose. In blood, at both IL-7 doses, responses were highest in influenzaspecific memory cells, progressively lower for the 2 EBV-specific populations, and lowest for CMV-specific memory. By contrast, in the tonsil, again at both IL-7 doses, CMV-specific memory responses were higher than those of the 2 EBV-specific populations. Figure 5B shows the results of an independent experiment in which the different virus-specific memory T cell responses were compared in blood versus tonsil across a range of IL-7 concentrations, and the results are presented graphically as a dose response. These results confirm the pattern already apparent in figure 5A . When the different virus-specific populations were compared, a different hierarchy of responsiveness was observed in blood versus tonsil. Furthermore, these different hierarchies correlated strongly with the different level of IL-7Ra expression seen on virus-specific populations in blood versus tonsil, as already described in figures 2 and 4.
Relationship to the activation/differentiation phenotypes of virus-specific memory cells at the 2 sites. Our earlier studies of virus-specific effector cells activated in vivo during primary EBV or CMV infection showed that activation leads to the transient down-regulation of IL-7Ra [20] . This is illustrated in figure 6A , which shows that a highly expanded EBV lytic epitope-specific population in the blood of a patient with acute EBV infectious mononucleosis (IM) is almost uniformly IL7Ra negative and shows a reciprocal up-regulation of the activation marker CD38. We therefore studied influenza-specific, EBV latent-specific, EBV lytic-specific, and CMV-specific memory-cell populations in blood from healthy donors, to determine whether the differences in their IL-7Ra status was due to differential levels of activation as reflected by CD38 expression. In fact, as shown in figure 6B , this was not the case; all 4 populations were predominantly CD38 negative. Furthermore, tonsillar populations of virus-specific cells were all essentially similar to the blood populations in their CD38 profiles (figure 6C).
We then turned to another aspect of the memory CD8 phenotype that has been observed to distinguish between different virus-specific reactivities in the blood: the distribution between Ϫ central memory, the CCR7 Ϫ CD45RA Ϫ effector memory, and CCR7 Ϫ CD45RA + terminally differentiated compartments. Figure 7A shows typical profiles of the different virus-specific populations in blood. Influenza-specific and EBV latent epitope-specific memory cells tend to be evenly split between central memory and effector memory compartments. In comparison, EBV lytic epitope-specific memory is shifted more toward an effector phenotype, with a few cells even acquiring terminally differentiated status, and CMV-specific memory is very largely within the terminally differentiated compartment, in accordance with previous results [11] [12] [13] [14] [15] [16] . We therefore sought to characterize virus-specific memory populations in the tonsil with the same differentiation markers, given that the patterns of IL-7Ra expression on such cells were quite different in blood and tonsil. Despite these contrasting IL-7Ra profiles in the 2 sites, the different virus-specific populations in tonsil retained the same differentiation profiles as in blood. As illustrated in figure 7B , the EBV latent epitope-specific population in tonsil remained equally split between central memory and effector memory phenotypes; EBV lytic epitope-specific cells again showed a highest shift toward the effector compartment, and CMV-specific cells were again mostly terminally differentiated.
DISCUSSION
We began these studies in light of observations about patients with IM recovering from primary EBV infection, in whom the recovery of IL-7Ra expression on emerging CD8 + T cell memory was consistently slower and less marked for EBV lytic than for latent epitope reactivities [20] . These differences also correlated with a slower shift of lytic epitope-specific memory toward the CCR7 + CD45RA
Ϫ central memory phenotype [18] .
Given the work in mouse models that indicated that IL-7Ra recovery was less complete on memory to persistent than to nonpersistent viruses [9, 10] , we extended the work to include a nonpersistent infection-influenza-and a second persistent agent-CMV-alongside EBV in the analysis. The present findings, based on the study of 17 viral epitopes in 25 healthy donors, clearly show that there is indeed a relationship between IL-7Ra on memory cells in blood and the type of virus. Influenza-specific memory cells are 80%-100% IL-7Ra positive, and the mean value decreases through EBV latent and lytic reactivities to a minimum of ∼30% IL-7Ra for CMV-specific memory. A recent article, which mainly compared influenza-and CMV-induced responses, reported a similar trend [21] , in agreement with the broad notion of a difference between nonpersistent and persistent agents. However, our present, moreextensive analysis shows that a striking inverse relationship with response size is superimposed on this pattern. This is apparent not just within the relatively large range of response sizes seen for CMV and for EBV lytic epitope-specific memory but even within the smaller range of influenza responses. Within each group, the larger the individual epitope response, the lower the proportion of memory cells in blood that are IL-7Ra positive.
Studies of primary infection with EBV [20] and CMV [21] have confirmed that antigen-activated CD8 + T cells down-regulate IL-7Ra expression and up-regulate the activation antigens such as CD38. It is therefore conceivable that, in long-term carriers of these viruses, the presence of a fraction of IL-7Ra-negative virus-specific memory cells reflects recent antigen restimulation in vivo [27] . Indeed, this may well be the case in a situation such as chronic HIV carriage, where ongoing virus replication can be intense [28] . However, in the case of both EBV and CMV, we found no evidence of significant virusspecific activation; thus, the great majority of memory cells in the blood were CD38
Ϫ , and the minority of cells that did express CD38 were no more numerous for memory to these viruses than for influenza-specific memory. However, it is worth noting that, in our earlier studies of patients with IM [20] , the reacquisition of IL-7Ra on cells after antigenic stimulation took months to years to complete, long after emerging EBV-specific memory cells had lost their initial CD38 marker of activation. Thus, the failure of circulating memory cells in persistent virus carriers to ever become 100% IL-7Ra positive may reflect occasional restimulation by antigen in vivo. Indeed, the more highly amplified responses, which showed the lowest levels of IL-7Ra expression, may be those most prone to antigen reexposure in vivo, because memory populations immunodominant CMV epitopes do show progressive increases in size over time [23, 29] , and a similar effect has been seen under certain circumstances with EBV [23, 30] . The occasional reexposure of individuals to antigenically related influenza viruses over time could likewise serve to boost influenza-specific memory, albeit not as regularly as with a persistent agent. On the basis of the data available in humans so far, we believe that it is premature to draw firm correlations between the IL-7Ra status of circulating memory cells and the persistent/nonpersistent nature of viral infection when the absolute size of the memory population in blood appears to be an important covariable.
In their earlier study, van Leeuwen et al. [21] drew a parallel between IL-7Ra status on virus-specific CD8 + T cells in blood and the CD27 costimulation marker. However, this is clearly not the case, because many EBV latent and particularly EBV lytic memory cells are IL-7Ra negative in healthy donors, yet these cells are almost uniformly CD27 + [1, 16, 18] . A closer possible correlate would be IL-7Ra and CD28, but even this correlation does not hold, because CMV-specific memory populations are, on average, 30% IL-7Ra positive in blood, yet almost all of these cells lack CD28 [1, 28] [31, 32] . Thus, although in mice IL-7Ra expression has been reported to be a marker that is lost with the transition from central to effector memory on CD8 + T cells [33, 34] , there is no absolute correlation between IL-7Ra and other markers of CD8 differentiation in humans.
Arguably the most interesting finding in the present work is the influence of location on the IL-7Ra status of human virusspecific populations in vivo. In this context, most studies to [9, 10, 33] . However, in a recent study of persistent infection with murine CMV, it was clear that the percentage of virus-specific CD8 + T cells that are IL-7Ra positive varied significantly with tissue site, even when sites where the size of the virus-specific population is similar were compared [33] . Little is known about humans in this regard, except for one recent study in which the IL-7Ra status of different virus-specific memory CD8 + T cells was examined in lungs. For each virus studied, the IL7Ra profiles seen for memory cells in lungs was broadly similar to that seen in blood, even though the relative representation of respiratory virus-specific memory was enhanced in lungs, compared with EBV-or CMV-specific memory [35] . Our study makes it clear that in at least 1 lymphoid site, the tonsil, the clear differences in IL-7Ra status seen in blood among EBV latent, EBV lytic, and CMV reactivities no longer hold. At that site, all 3 populations are highly IL-7Ra positive, with CMVspecific CD8 + memory in fact showing the high percentage of positivity. As we already reported [22] , the relative representation of these populations in tonsillar CD8 + T cells is markedly different from in the blood, with EBV-specific reactivities significantly enriched, CMV reactivities relatively rare, and influenza reactivities undetectable. This may reflect different homing properties imposed on these different populations at the time of priming, as has been reported in several murine studies [36] [37] [38] [39] . This could also explain why influenza-specific cells congregate in lungs [35] and EBV-specific cells in oropharyngeal tissues stay present in both cases without obvious signs of local antigenic challenge detectable by activation status. An important finding was that the EBV latent-specific, EBV lytic-specific, and CMV-specific memory populations in tonsil retained their distinctive CCR7/CD45 differentiation phenotypes, just as is seen in blood. To our knowledge, this extension of the virus-specific memory profile to a site other than blood has not been reported before in human studies. It does suggest that these different signatures, which, at least for the 2 EBVspecific [20] and for CMV-specific [20, 21] populations appear to be imposed soon after primary virus infection, are not just features of circulating cells but will also be apparent at other in vivo sites. By contrast, the IL-7Ra status on CD8 + T cells is clearly more sensitive to local environmental influences, albeit for reasons that are still not clear. Because IL-7Ra expression clearly does correlate with IL-7 responsiveness in our in vitro assays, it may be important that all memory cells become receptive for IL-7-mediated growth/survival signals [7, 9] at particular sites in vivo, and tonsillar tissue is one such site. Our findings clearly highlight the plasticity of IL-7Ra expression at the level of individual CD8 + T cells in vivo and the dangers inherent in using IL-7Ra status as a differentiation marker.
